참고문헌
- Abbady AQ, Bronner C, Bathami K, et al (2005). TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. Biochem Pharmacol, 70, 570-9. https://doi.org/10.1016/j.bcp.2005.05.012
- Achour M, Mousli M, Alhosin M, et al (2013). Epigallocatechin-3-gallate up-regulates tumor suppressor gene expression via a reactive oxygen species-dependent down-regulation of UHRF1. Biochem Biophys Res Commun, 430, 208-12. https://doi.org/10.1016/j.bbrc.2012.11.087
- Alhosin M, Sharif T, Mousli M, et al (2011). Down-regulation of UHRF1, associated with re-expression of tumor suppressor genes, is a common feature of natural compounds exhibiting anti-cancer properties. J Exp Clin Cancer Res, 30, 41. https://doi.org/10.1186/1756-9966-30-41
- Arima Y, Hirota T, Bronner C, et al (2004). Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition. Genes to Cells, 9, 131-42. https://doi.org/10.1111/j.1356-9597.2004.00710.x
- Dandache I, et al (2012). Anti-cancer properties of cranberry juice in human colon cancer: Characterization of the cellular and molecular mechanisms. Fundament Clin Pharmacol, 26, 40.
- Fang L, Shanqu L, Ping G, et al (2012). Gene therapy with RNAi targeting UHRF1 driven by tumor-specific promoter inhibits tumor growth and enhances the sensitivity of chemotherapeutic drug in breast cancer in vitro and in vivo. Cancer Chemotherapy Pharmacol, 69, 1079-87. https://doi.org/10.1007/s00280-011-1801-y
- Geng Y, Gao Y, Ju H, et al (2012). Diagnostic and prognostic value of plasma and tissue ubiquitin-like, containing PHD and RING finger domains 1 in breast cancer patients. Cancer Science, 104, 194-9.
- Jenkins Y, Markovtsov V, Lang W, et al (2005). Critical role of the ubiquitin ligase activity of UHRF1, a nuclear RING finger protein, in tumor cell growth. Molecular Biology of the Cell, 16, 5621-9. https://doi.org/10.1091/mbc.E05-03-0194
- Mousli M, Hopfner R, Abbady AQ, et al (2013). ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells. Br J Cancer, 89, 120-7.
- Tien AL, Senbanerjee S, Kulkarni A, et al (2011). UHRF1 depletion causes a G2/M arrest, activation of DNA damage response and apoptosis. Biochemical J, 435, 175-85. https://doi.org/10.1042/BJ20100840
- Wang F, Yang YZ, Shi CZ, et al (2012). UHRF1 promotes cell growth and metastasis through repression of p16 ink4a in colorectal cancer. Ann Surgical Oncol, 19, 2753-62. https://doi.org/10.1245/s10434-011-2194-1
- Yang G.L, Zhang LH, Bo JJ, et al (2012). UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer. Medical Oncol, 29, 842-7. https://doi.org/10.1007/s12032-011-9983-z
피인용 문헌
- miR-124 exerts tumor suppressive functions on the cell proliferation, motility and angiogenesis of bladder cancer by fine-tuning UHRF1 vol.282, pp.22, 2015, https://doi.org/10.1111/febs.13502
- Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells vol.5, pp.1, 2015, https://doi.org/10.1038/srep16415
- Inhibition of Human Glioma Cell Proliferation Caused by Knockdown of Utrophin Using a Lentivirus-Mediated System vol.31, pp.4, 2016, https://doi.org/10.1089/cbr.2015.1939